Literature DB >> 24732942

Basic research: Rebooting rhabdomyosarcoma's operating system.

M Teresa Villanueva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24732942     DOI： 10.1038/nrclinonc.2014.62

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.

Authors:  Eleanor Y Chen; Michael T DeRan; Myron S Ignatius; Kathryn Brooke Grandinetti; Ryan Clagg; Karin M McCarthy; Riadh M Lobbardi; Jillian Brockmann; Charles Keller; Xu Wu; David M Langenau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.